Please assess the completion status of the following clinical trial:

Trial Title: High Dose of Dual Therapy Plus Metronidazole for Helicobacter Pylori RescueTreatment

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Participants with non-ulcer functional dyspepsia or peptic ulcer disease~* Ability and willingness to participate in the study and to sign and give informed consent~* Confirmed H. pylori infection and with previous treatment failure~Exclusion Criteria:~* Less than 18 years old or older than 80 years~* With previous gastric surgery~* Major systemic diseases~* Pregnancy or lactation~* Allergy to any of the study drugs~* Administration of antibiotics, bismuth,antisecretory drugs in 8 weeks prior to inclusion

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Dual therapy (Type: ACTIVE_COMPARATOR): Esomeprazole 40mg bid and Amoxicillin 1.0g tid for 14 days
- Metronidazole plus dual therapy (Type: EXPERIMENTAL): Esomeprazole 40mg bid, Amoxicillin 1.0g tid and Metronidazole 0.4g tid for 14 days

Based on this trial design, predict the completion outcome and termination type (if applicable).